ARS Pharmaceuticals

ARS Pharmaceuticals is a stealth pharmaceutical company that specializes in developing anti allergy drugs.

Funding reportedLast round: Series D

BiopharmaSan Diego, United States

What company datasets say ARS Pharmaceuticals raised

Funding, as reported

Reported in all$100Min dollars

Rounds2

Last roundSeries D

Last round dateAug 2021

Investors listed4

SEC Form D$63M sold, 2 filings, last Sept 2021

From the SEC filings it signed: 2 on the team.

On the board, as filediBrent SaundersJonathan LeffMike KellyPeter KolchinskyPhil SchneiderPratik ShahRajeev Dadoo

Investors who name them

Each firm lists ARS Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put ARS Pharmaceuticals in front of investors. Or tell us what we have wrong.